Versions Compared
compared with
Key
- This line was added.
- This line was removed.
- Formatting was changed.
Cancer Synoptic Reporting Project Group
5
21 April at
1716:00 - 18:30 UTC
Attendees
Scott Campbell Jim Case Monica de Baca Stefan Dubois Sandy Jones connie boone
@Apologies
Discussion items
Item | Description | Owner | Notes | Action | |||||
---|---|---|---|---|---|---|---|---|---|
1 | Conflict of Interest | ||||||||
2Project updates | Concepts promoted to task and in queue for promotion |
| 3 | Lymph-vascular body structure | Review/discuss body structure concept for lymph vessel and/or small blood vessel body structure | Definition added to concept to indicate that "small vessels" include lymphatic vessels, arterioles, capillaries and venules. ||||
4 | Method used to "grade" or "stage" | Review/discuss general observable for "Method used to..." | Delete concept for |Method used to calculate Gleason score|. Create observables that use technique = specific method as subtype of Gleason score (observable entity). | ||||||
| |||||||||
3 | Concepts in review for inclusion in task | Scott Campbell |
|
| |||||
45 | Grade finding (finding) | Scott Campbell | Discuss clinical finding concepts in existing SI content. To inactivate or not | Jim Case to draft letter to Jeremy Rogers to discuss UK use of Grade (findings) in light of Grade (qualifiers) used in CSRWG. Suzanne Santamaria to pre-review letter. | - Follow up with UK use case |
| |||
5 | Next concepts |
|
| ||||||
6 | Business meeting | I&E documents to do and review | Cancer Synoptic Reporting | ||||||
7 | Histology discussion | Removal of 86049000 |Malignant neoplasm, primary (morphologic abnormality)| and similar high-level concepts. Challenge for this group and disorders. Removal of concepts like: 2092003 |Malignant melanoma, no International Classification of Diseases for Oncology subtype (morphologic abnormality)| |
Note: primary/secondary/metastatic/unknown/post-treatment tumors discussion needs to move back to editorial advisory group. FSN implications and definitions....more discussion needed. How does this impact grouper concepts | 6 | Specimen type question | Discuss use of Tissue specimen obtained by excision for use in template | Tissue specimen obtained by excision to be used in templates. Subsumes all necessary procedures in CSR work group scope. |
Meeting Files
Attachments |
---|
Previous Meetings
Content Report Table | ||||||||
---|---|---|---|---|---|---|---|---|
|